LINEAGE CELL THERAPEUTICS IN

Ticker: LCTX CUSIP: 53566P109 Class: COM

LINCOLN NATIONAL CORP's Holding History (CIK: 0000059558)

Note: Option positions (PUT/CALL) are excluded.

Q1 2023
Shares 156,225 Value ($000) $234 Avg Close $1.40 Range $1.16 - $1.58
Q4 2022
Shares 155,700 Value ($000) $182 Avg Close $1.26 Range $1.02 - $1.51
Q3 2022
Shares 217,700 Value ($000) $246 Avg Close $1.47 Range $1.11 - $1.79
Q2 2022
Shares 251,500 Value ($000) $397 Avg Close $1.32 Range $1.10 - $1.64
Q1 2022
Shares 192,900 Value ($000) $297 Avg Close $1.55 Range $1.18 - $2.58
Q4 2021
Shares 193,500 Value ($000) $474 Avg Close $2.34 Range $1.80 - $2.71
Q3 2021
Shares 154,600 Value ($000) $390 Avg Close $2.57 Range $2.26 - $2.90